ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 75 filers reported holding ALLAKOS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $32,365,000 | +24.0% | 305,706 | 0.0% | 0.68% | +32.0% |
| Q2 2021 | $26,098,000 | -25.6% | 305,706 | 0.0% | 0.52% | -32.6% |
| Q1 2021 | $35,089,000 | -26.6% | 305,706 | -10.5% | 0.77% | -24.5% |
| Q4 2020 | $47,810,000 | +143.0% | 341,500 | +41.4% | 1.01% | +103.2% |
| Q3 2020 | $19,677,000 | +14.6% | 241,582 | +1.1% | 0.50% | +5.9% |
| Q2 2020 | $17,177,000 | +64.3% | 239,032 | +1.7% | 0.47% | +9.0% |
| Q1 2020 | $10,455,000 | -53.3% | 235,000 | 0.0% | 0.43% | -39.0% |
| Q4 2019 | $22,410,000 | -1.7% | 235,000 | -19.0% | 0.71% | -22.1% |
| Q3 2019 | $22,803,000 | +30.3% | 290,000 | -28.2% | 0.91% | +43.6% |
| Q2 2019 | $17,505,000 | +7.0% | 404,000 | 0.0% | 0.63% | +0.3% |
| Q1 2019 | $16,362,000 | -22.5% | 404,000 | 0.0% | 0.63% | -36.7% |
| Q4 2018 | $21,117,000 | +15.9% | 404,000 | -0.2% | 1.00% | +51.1% |
| Q3 2018 | $18,221,000 | – | 405,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |